266 related articles for article (PubMed ID: 20360137)
1. The future of aptamers in medicine.
Khati M
J Clin Pathol; 2010 Jun; 63(6):480-7. PubMed ID: 20360137
[TBL] [Abstract][Full Text] [Related]
2. Aptamers: from bench side research towards patented molecules with therapeutic applications.
Majumder P; Gomes KN; Ulrich H
Expert Opin Ther Pat; 2009 Nov; 19(11):1603-13. PubMed ID: 19852719
[TBL] [Abstract][Full Text] [Related]
3. [Aptamers in clinical diagnostics].
Szpechciński A; Grzanka A
Postepy Biochem; 2006; 52(3):260-70. PubMed ID: 17201061
[TBL] [Abstract][Full Text] [Related]
4. Complex target SELEX.
Shamah SM; Healy JM; Cload ST
Acc Chem Res; 2008 Jan; 41(1):130-8. PubMed ID: 18193823
[TBL] [Abstract][Full Text] [Related]
5. Nanotechnology and aptamers: applications in drug delivery.
Levy-Nissenbaum E; Radovic-Moreno AF; Wang AZ; Langer R; Farokhzad OC
Trends Biotechnol; 2008 Aug; 26(8):442-9. PubMed ID: 18571753
[TBL] [Abstract][Full Text] [Related]
6. Aptamers come of age - at last.
Bunka DH; Stockley PG
Nat Rev Microbiol; 2006 Aug; 4(8):588-96. PubMed ID: 16845429
[TBL] [Abstract][Full Text] [Related]
7. The development and testing of aptamers for cancer.
Barbas AS; White RR
Curr Opin Investig Drugs; 2009 Jun; 10(6):572-8. PubMed ID: 19513946
[TBL] [Abstract][Full Text] [Related]
8. Aptamers-based assays for diagnostics, environmental and food analysis.
Tombelli S; Minunni M; Mascini M
Biomol Eng; 2007 Jun; 24(2):191-200. PubMed ID: 17434340
[TBL] [Abstract][Full Text] [Related]
9. Targeting cancer cells with nucleic acid aptamers.
Cerchia L; de Franciscis V
Trends Biotechnol; 2010 Oct; 28(10):517-25. PubMed ID: 20719399
[TBL] [Abstract][Full Text] [Related]
10. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
11. [Current reviews in aptamers].
Wang C; Mo Z
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Apr; 23(2):463-6. PubMed ID: 16706390
[TBL] [Abstract][Full Text] [Related]
12. Nucleic acid aptamers as tools and drugs: recent developments.
Rimmele M
Chembiochem; 2003 Oct; 4(10):963-71. PubMed ID: 14523912
[TBL] [Abstract][Full Text] [Related]
13. Nucleic acid-based aptamers as promising therapeutics in neoplastic diseases.
Cerchia L; de Franciscis V
Methods Mol Biol; 2007; 361():187-200. PubMed ID: 17172712
[TBL] [Abstract][Full Text] [Related]
14. Aptamer applications for targeted cancer therapy.
Barbas AS; Mi J; Clary BM; White RR
Future Oncol; 2010 Jul; 6(7):1117-26. PubMed ID: 20624124
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy progress and prospects: RNA aptamers.
Que-Gewirth NS; Sullenger BA
Gene Ther; 2007 Feb; 14(4):283-91. PubMed ID: 17279100
[TBL] [Abstract][Full Text] [Related]
16. Aptamers--basic research, drug development, and clinical applications.
Proske D; Blank M; Buhmann R; Resch A
Appl Microbiol Biotechnol; 2005 Dec; 69(4):367-74. PubMed ID: 16283295
[TBL] [Abstract][Full Text] [Related]
17. In vitro selection of protein-binding DNA aptamers as ligands for biosensing applications.
Navani NK; Mok WK; Yingfu L
Methods Mol Biol; 2009; 504():399-415. PubMed ID: 19159108
[TBL] [Abstract][Full Text] [Related]
18. Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.
Pangburn TO; Petersen MA; Waybrant B; Adil MM; Kokkoli E
J Biomech Eng; 2009 Jul; 131(7):074005. PubMed ID: 19655996
[TBL] [Abstract][Full Text] [Related]
19. Using aptamers to identify and enter cells.
Chu T; Ebright J; Ellington AD
Curr Opin Mol Ther; 2007 Apr; 9(2):137-44. PubMed ID: 17458167
[TBL] [Abstract][Full Text] [Related]
20. Aptamers: the emerging class of future anticoagulation for vascular disease.
Kuliczkowski W; Floyd J; Malinin A; Serebruany V
Expert Rev Cardiovasc Ther; 2010 Apr; 8(4):503-7. PubMed ID: 20397824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
